{"id":"W2150436558","doi":"10.1016/s0140-6736(04)17398-4","title":"Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial","year":2004,"lang":"en","type":"article","venue":"The Lancet","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":1643,"is_retracted":false,"has_abstract":false,"ca_institutions":"McGill University","funders":"GlaxoSmithKline","keywords":"Medicine; Vaccine efficacy; Vaccination; Immunogenicity; HPV infection; Adjuvant; HPV vaccines; Cervical cancer; Randomized controlled trial; Incidence (geometry); Internal medicine; Immunology; Antibody; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null}